Major Markets
- Neurodegenerative Disorders = $85 Billion (US)
- i.e. Parkinson’s & Alzheimer’s Diseases
- Chronic/Neuropathic Pain = $650 Billion (US)
- i.e. Neuropathic Pain & HIV Neuropathy
- Cardiovascular Disease = $316 Billion (US)
- i.e. Prevention & Treatment of Cardiac Hypertrophy
- Inflammatory Conditions = $200 Billion (US)
- i.e. Rheumatoid arthritis & Mast Cell Activation Syndrome
